MARC is a medical technology training facility that offers surgical training for a variety of specialties. MARC claimed that it offers as many as forty, state-of-the art bio skill lab stations in a hospital style setting alongside custom designed conference and lecture facilities delivering full videoconferencing in a dedicated facility.

Jack Lennon, president of UV Flu Technologies, said: “This order is significant when you consider the client’s needs and perspective. They are an internationally-respected medical facility that instructs a diverse client list of doctors, surgeons and other talented practitioners of the medical profession from throughout the western hemisphere.

“We trust that other teaching facilities, at home and abroad, will take note and quickly identify that our product offers a cost effective and easy to implement method to increase the overall safety level of any facility by immediately lessening the risk of airborne bacteria, and one that also limits the spread of noxious odors and Volatile Organic Compounds (VOC).

“The ViraTech UV-400 is specifically designed to kill dangerous strains of bacteria which may present themselves from time to time, while also reducing the levels of other contaminants and odors from the air we breathe.”

About UV Flu Technologies is a developer, manufacturer and distributor of bio technology products initially targeting Indoor Air Quality (IAQ) industry sector.

The company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.